Status:

COMPLETED

Cell Signaling and Resistance to Oxidative Stress: Effects of Aging and Exercise

Lead Sponsor:

Northern Arizona University

Conditions:

Aging

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Advanced age is the main risk factor for chronic diseases such as cardiovascular disease, type 2 diabetes, Alzheimer's disease and cancer. One reason may be due to decreased resistance to oxidative st...

Detailed Description

Advanced age substantially increases the risk for a host of diseases including cardiovascular disease, type 2 diabetes, Alzheimer's disease, and cancer. A major factor that appears to underlie this in...

Eligibility Criteria

Inclusion

  • Men and women, 18-28 years or 60 years and older
  • Competent to independently give informed consent
  • Successful completion of screening
  • No regular exercise for the past 6-months (by self-report)
  • A score below 3.0 on the Historical Lifetime Physical Activity Questionnaire

Exclusion

  • Estrogen supplementation within the previous 6 months
  • Use of anti-oxidant supplements, in excess of standard multi-vitamins (1 tablet/day)
  • Current smoker
  • Body Mass Index (BMI) ≤33 kg/m2 (Class I Obesity)
  • Any chronic illness that could affect outcome measures, including diabetes, liver or renal disease, or cancer (other than skin cancer)
  • History of a myocardial infarction within the last 6 months, clinically significant aortic stenosis, use of cardiac defibrillator, or uncontrolled angina
  • Clinically significant arrhythmia on a resting EKG or significant EKG changes during the baseline maximal oxygen consumption (VO2 max) test
  • Any other condition that would contraindicate maximal exercise testing, including elevated blood pressure at rest (systolic BP \>150 or diastolic BP \>90 mm Hg on at least 2 measurements, at least 10 minutes apart) or musculoskeletal problems

Key Trial Info

Start Date :

June 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2020

Estimated Enrollment :

46 Patients enrolled

Trial Details

Trial ID

NCT03419988

Start Date

June 1 2017

End Date

June 30 2020

Last Update

August 26 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Northern Arizona University

Flagstaff, Arizona, United States, 86011